Design concepts and principle of operation of the HeartWare ventricular assist system.
暂无分享,去创建一个
Daniel Tamez | Michael Ashenuga | Carlos Reyes | C. Reyes | D. Tamez | J. Larose | Michael Ashenuga | Jeffrey A Larose
[1] James W Long,et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. , 2005, Congestive heart failure.
[2] R. Schwartzman,et al. Neurologic complications of the Novacor left ventricular assist device. , 2001, The Annals of thoracic surgery.
[3] W. Holman. Microbiology of Infection in Mechanical Circulatory Support , 2007, The International journal of artificial organs.
[4] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[5] Nader Moazami,et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.
[6] T. Myers,et al. Infectious complications associated with ventricular assist systems. , 2000, ASAIO journal.
[7] S. Furukawa,et al. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation , 2005, Transplant infectious disease : an official journal of the Transplantation Society.
[8] M. Oz,et al. Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[9] Thierry G Mesana,et al. Rotary blood pumps for cardiac assistance: a "must"? , 2004, Artificial organs.
[10] G. Beilman,et al. Abdominal complications of ventricular assist device placement. , 2005, Surgical infections.
[11] B. Hota,et al. Left ventricular assist device-related infection: treatment and outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] P M Portner,et al. Improved outcomes with an implantable left ventricular assist system: a multicenter study. , 2001, The Annals of thoracic surgery.
[13] G. Couper,et al. Infection in permanent circulatory support: experience from the REMATCH trial. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[14] V. Jeevanandam,et al. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. , 1996, Circulation.